Transcatheter heart valves technologies

Feasibility of transcaval access TAVI in morbidly obese patients: A single‐center experience

Published on 17/11/2022 | Michael Michail et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30465 | 11 minute read

Abstract Objectives We report a single‐center experience in utilizing the transcaval‐access transcatheter aortic valve implantation (TAVI) as an alternative approach

Transcatheter heart valves technologies

Use of Virtual Reality for procedural planning of Transcatheter Aortic Valve Replacement

Published on 17/11/2022 | Xavier Ruyra et al. | Interactive CardioVascular and Thoracic Surgery 2022; aop: 10.1093/icvts/ivac248 | 1 minute read

Abstract This study sought to evaluate the impact of Virtual Reality (VR) tools in procedural planning of transcatheter aortic

Transcatheter heart valves technologies

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement

Published on 03/11/2022 | Mark Lachmann 1 et al. | Open Heart 2022; 9(2): e002068 | 30 minute read

Abstract Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic

Transcatheter heart valves technologies

Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database

Published on 20/10/2022 | Waqas Ullah MD 1 et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30407 | 22 minute read

Abstract Background Transcatheter aortic valve implantation (TAVI) has increasingly been utilized in patients with bicuspid aortic valve (BAV) related aortic

Transcatheter heart valves technologies

The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties

Published on 20/10/2022 | Jurrien ten Berg et al. | European Heart Journal 2022; aop: 10.1093/eurheartj/ehac385 | 49 minute read

Abstract Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure, which is used frequently in patients with symptomatic severe

Transcatheter heart valves technologies

Rationale, Definitions, Techniques, and Outcomes of Commissural Alignment in TAVR From the ALIGN-TAVR Consortium

Published on 06/10/2022 | Tang et al. | JACC. Cardiovascular interventions 2022; 15(15): 1497-518 | 0 minute read

Transcatheter heart valves technologies

Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial

Published on 15/09/2022 | Taishi OkunoMD 1 et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30370 | 17 minute read

Abstract Background Midterm data comparing clinical outcomes after successful implantation of self‐expanding and balloon‐expandable transcatheter heart valves (THV) are limited.

Transcatheter heart valves technologies

Trends, Predictors, and Outcomes of 30‐Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database

Published on 15/09/2022 | SalmanZahidMD 1 et al. | Journal of the American Heart Association 2022; 11(16): 024890 | 25 minute read

Abstract Background Data on trends, predictors, and outcomes of heart failure (HF) readmissions after transcatheter aortic valve replacement (TAVR) remain

Transcatheter heart valves technologies

Outcomes After Transcatheter Aortic Valve Implantation in Men Versus Women

Published on 01/09/2022 | Wöhrle et al. | The American Journal of Cardiology 2022; aop:10.1016/j.amjcard.2022.06.035 | 0 minute read

Transcatheter heart valves technologies

Value of Periprocedural Electrophysiology Testing During Transcatheter Aortic Valve Replacement for Risk Stratification of Patients With New‐Onset Left Bundle‐Branch Block

Published on 18/08/2022 | PatrickBadertscherMD 1 et al. | Journal of the American Heart Association 2022; 11(15): 026239 | 21 minute read

Abstract Background Despite being the most frequent complication following transcatheter aortic valve replacement (TAVR), optimal management of left bundle‐branch block

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.